gohiam.com
Edit

UT Health San Antonio

http://www.uthscsa.edu/
Last activity: 25.06.2026
Active
Categories: CareCenterEdTechHealthTechITResearchScienceServiceTrainingUniversity
The University of Texas Health Science Center at San Antonio is now called UT Health San Antonio. We remain dedicated to providing the best in health careers education, biomedical research, patient care and community service to San Antonio and the South Texas/Border Region. Through undergraduate, graduate and postgraduate programs, the faculty is committed to educating health professionals who will provide excellent patient care and research that can be applied to treat and prevent disease.

UT Health San Antonio serves San Antonio and the 50,000 square-mile area of South Texas. It extends to campuses in the metropolitan border communities of Laredo, Harlingen, Edinburg and the Rio Grande Valley.

For more information on the many ways we make lives better, visit uthealthsa.org.
Likes
14.27K
Followers
1.52K
Website visits
486.5K /mo.
Mentions
52
Location: United States, Texas, San Antonio
Employees: 5001-10000
Phone: +1 210-567-7000
Founded date: 1959

Mentions in press and media 52

DateTitleDescription
25.06.2026This 29-year-old is training to be a flight surgeon and has nearly $1.2 million investedThis story is part of CNBC Make It’s Millennial Money series, which examines how people earn, spend and save their money. Eric Chan has two passions in life: medicine and aviation. “I’ve always known that I wanted to become a doctor,” the 2...
26.03.2026Qualified Health Raises $125M in Series B FundingQualified Health, a Palo Alto, CA-based company providing an enterprise AI platform built for health systems, raised $125M in Series B funding The round was led by New Enterprise Associates, Inc. (NEA), with participation from new investors...
03.02.2026Biosion Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial of BSI-082, a Next-Generation Anti-SIRPα Monoclonal Antibody for Advanced Solid TumorsMilestone validates the clinical potential of BSI-082 as a synergistic combination partner for antibody-drug conjugates (ADCs) and reinforces Biosion's "In Global, For Global" collaboration strategy. NEWARK, Del. and NANJING, Chin...
09.12.2025Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer SymposiumIn addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine therapy in combination settings, as well as in both metastatic and early stage breast cancer. FLORENCE, Italy and NE...
18.06.2025The Silent Saboteur: Understanding Oxidative Stress and the Power of Plant-Based NutritionIn the intricate dance of life, our bodies are constantly battling unseen foes. One of the most insidious of these is oxidative stress. It lurks in the shadows, quietly wreaking havoc on our health. But there’s a beacon of hope: plant-based...
17.06.2025Amaros Closes Series A FinancingAmaros, an Atherton, CA-based ophthalmic intelligence company and a developer of AI-powered EvidenceEngine platform, raised an undisclosed amount in Series A funding. Backers were not disclosed. The company intends to use the funds to accel...
03.02.2025Pirche AG Announces Partnership with UT Health San AntonioPirche AG has today announced an ongoing partnership with UT Health San Antonio, which gives the university access to the novel TxPredictor platform. GRüNWALD, BAVARIA, GERMANY, February 3, 2025 /EINPresswire.com/ -- Pirche AG has today ann...
03.02.2025Houston Nobel Prize nominee earns latest award for public health researchHouston vaccine scientist Dr. Peter Hotez can add one more prize to his shelf. Hotez — dean of the National School of Tropical Medicine and professor of Pediatrics and Molecular Virology & Microbiology at Baylor College of Medicine, co-...
07.01.2025BerGenBio Announces First Patient Entered Into Advanced Adenocarcinoma Lung Cancer TrialBerGenBio Announces First Patient Entered Into Advanced Adenocarcinoma Lung Cancer Trial Tue, Jan 07, 2025 07:00 CET Report this content Bergen, Norway, January 7, 2025 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical compan...
12.12.2024KIND Presents Preclinical Results of AND017 in Animal Models of Sickle Cell Disease (SCD), Myelodysplastic Syndromes (MDS), and β-Thalassemia at the 66th American Society of Hematology Meeting and Exp...SAN FRANCISCO, Dec. 12, 2024 /PRNewswire/ -- Kind Pharmaceutical ("Hangzhou Andao Pharmaceutical Ltd. and Kind Pharmaceuticals LLC"), a clinical-stage biopharmaceutical company focused on developing innovative medicines to treat h...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In